ARISTADA
NDC 65757-403, aripiprazole lauroxil, injection, suspension, extended release, from Alkermes, Inc..
- Product NDC
- 65757-403
- Status
- Listed
- Labeler
- Alkermes, Inc.
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207533
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65757-403 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ARIPIPRAZOLE LAUROXIL882 mg/3.2mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65757-403-03 | 65757040303 | 1 SYRINGE in 1 CARTON (65757-403-03) / 3.2 mL in 1 SYRINGE |
| 65757-403-04 | 65757040304 | 1 SYRINGE in 1 CARTON (65757-403-04) / 3.2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/17a8d11b-73b0-4833-a0b4-cf1ef85edefbMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65757-403NADAC price for package 65757040303
GET /v1/drugs/nadac/65757040303
Use it
Look up 65757-403 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65757-403 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65757-403. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.